The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 1 of the 29 sources its claims cite were checked for support.
The German Guidelines for the treatment of anxiety disorders: first revision
Open accessAbstract
Starting in 2019, the 2014 German Guidelines for Anxiety Disorders (Bandelow et al. Eur Arch Psychiatry Clin Neurosci 265:363–373, 2015) have been revised by a consensus group consisting of 35 experts representing the 29 leading German specialist societies and patient self-help organizations. While the first version of the guideline was based on 403 randomized controlled studies (RCTs), 92 additional RCTs have been included in this revision. According to the consensus committee, anxiety disorders should be treated with psychotherapy, pharmacological drugs, or their combination. Cognitive behavioral therapy (CBT) was regarded as the psychological treatment with the highest level of evidence. Psychodynamic therapy (PDT) was recommended when CBT was not effective or unavailable or when PDT was preferred by the patient informed about more effective alternatives. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs) are recommended as first-line drugs for anxiety disorders. Medications should be continued for 6–12 months after remission. When either medications or psychotherapy were not effective, treatment should be switched to the other approach or to their combination. For patients non-responsive to standard treatments, a number of alternative strategies have been suggested. An individual treatment plan should consider efficacy, side effects, costs and the preference of the patient. Changes in the revision include recommendations regarding virtual reality exposure therapy, Internet interventions and systemic therapy. The recommendations are not only applicable for Germany but may also be helpful for developing treatment plans in all other countries.
Overview
CoChat Summary
TL;DR
This paper presents the first revision of the German S3 guideline for adult anxiety disorders, based on a broader RCT evidence base and a 35-member expert consensus. It keeps CBT and SSRIs/SNRIs as the mainstay of treatment, while adding recommendations for internet interventions, virtual/augmented reality exposure, and systemic therapy.
Key findings
- The revision adds 92 new randomized controlled studies (RCTs) to the evidence base, which the abstract says expanded the earlier guideline built on 403 RCTs.
- Anxiety disorders should be treated with psychotherapy, pharmacological drugs, or their combination; the paper states that CBT has the highest level of evidence among psychological treatments.
- SSRIs and SNRIs are recommended as first-line drugs for anxiety disorders, and medications should be continued for 6–12 months after remission.
- The guideline does not recommend internet-based psychological interventions as monotherapy, but allows them as a bridge during waiting periods or as an add-on; it also limits VR/AR exposure mainly to adjunctive use or when in vivo exposure is unavailable.
Methods
- The guideline was developed by a consensus group of 35 experts drawn from psychiatry, psychosomatics/psychotherapy, general practice, psychology, relevant professional societies, and patient self-help organizations.
- The revision searched for RCTs published between 16/09/2013 and 20/06/2019, screened 638 newly found records plus prior guideline material, and ultimately included 92 new records.
- Study selection followed PRISMA, used explicit inclusion/exclusion criteria for adult anxiety disorders, and assessed RCT quality with SIGN Statement criteria; recommendations were approved by voting, requiring at least 75% of votes cast.
Limitations
- The paper states that for some topics there were too few studies or evidence was insufficient, such as VR for panic disorder and psychodynamic therapy relative to CBT.
- It also states that many IPI studies relied on unblinded self-ratings, and that in only 15% of those studies diagnoses were made by psychiatrists or psychologists in a personal interview; this is a limitation the text makes evident.
- The article notes that the full guideline contains 606 references and that not every statement is referenced in the paper itself, which limits how fully each recommendation can be traced in the article text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 7 Not valid · 26 Not checked · 48 Own results and interpretations
In the paper
“Published randomized studies on psychological therapies had an average study duration of 12.4 weeks [9], therefore, little is known about the additional benefits of psychotherapies that have 25, 50 or more sessions.”
§ The German Guidelines for the treatment of anxiety disorders: first revision > Results > Treatment
What the sources say
- Not checked yetcites [9] Bandelow B, Reitt M, Rover C, Michaelis S, Gorlich Y, Wedekind D (2015) Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol 30:183–192 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Only for specific phobias, drug studies are scarce, and behavioral treatments should be preferred.”
§ The German Guidelines for the treatment of anxiety disorders: first revision > Results > Virtual and augmented reality exposure treatment
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most efficacy studies used treatment manuals guiding the intervention strategy.”
§ The German Guidelines for the treatment of anxiety disorders: first revision > Results > Treatment
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, evidence showing that IPIs are as effective as individual CBT with face-to-face contact is insufficient.”
§ The German Guidelines for the treatment of anxiety disorders: first revision > Results > Treatment
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In comparison to CBT, the evidence for the efficacy of psychodynamic therapy (PDT) is weaker.”
§ The German Guidelines for the treatment of anxiety disorders: first revision > Results > Treatment
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
31 more claims
Create a free account to see all 82 claims and to verify the 27 references still open.
- Probably not a substantial claim. 26
- It may state two separate claims as one. 29
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The contents of Invirto are in line with national treatment guidelines for anxiety disorders [6], which are based on established German and international CBT treatment manuals for anxiety disorders [30–33].”
From Efficacy of an Internet-based intervention with self-applied exposure therapy in virtual reality for people with panic disorder: study protocol for a randomized controlled trial (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“According to German [6] and international guidelines such as the National Institute for Clinical Excellence (NICE; [7]), cognitive behavioral therapy (CBT) that includes exposure therapy is the first-line approach in the treatment of panic disorders (with or without agoraphobia).”
From Efficacy of an Internet-based intervention with self-applied exposure therapy in virtual reality for people with panic disorder: study protocol for a randomized controlled trial (2023) · cites this paper as [6]
Experimental — accuracy not yet measured
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Epidemiology of anxiety disorders in the 21st century
Bandelow, B., & Michaelis, S. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.3/bbandelow · Cited by 2,079 · cited 1×
“Anxiety disorders (Table 1) are the most prevalent psychiatric disorders and are associated with a high burden of illness [8].”
BackgroundSelf-citationPrevalence and Treatment of Mental Disorders, 1990 to 2003
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., Wang, P., Wells, K. B., & Zaslavsky, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa043266 · Cited by 1,910
JACOBI, F., WITTCHEN, H.-U., HÖLTING, C., HÖFLER, M., PFISTER, H., MÜLLER, N., & LIEB, R. (2004) · Psychological Medicine · doi:10.1017/s0033291703001399 · Cited by 1,097 · cited 1×
“These disorders often co-occur with other anxiety disorders, depression, somatoform, personality, and substance abuse disorders [19].”
BackgroundKatzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Self-citationJacobi, F., Höfler, M., Strehle, J., Mack, S., Gerschler, A., Scholl, L., Busch, M. A., Maske, U., Hapke, U., Gaebel, W., et al. (2014) · Der Nervenarzt · doi:10.1007/s00115-013-3961-y · Cited by 750
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
Self-citationPrevalence and Treatment of Mental Disorders
(2005) · New England Journal of Medicine · doi:10.1056/nejmc051936 · Cited by 650
Research works printed but not linked: 5
- ÄZQ/AWMF (2008) Deutsches instrument zur methodischen leitlinien-bewertung (delbi). AWMF, pp 468–519
- Bandelow B, Aden I, Alpers GW, Benecke A, Benecke C, Beutel ME, Deckert J, Domschke K, Eckhardt-Henn A, Geiser F, Gerlach AL, Harfst TH, Hoffmann S, Hoyer J, Hunger-Schoppe C, Kellner M, Köllner V, Kopp I, Langs G, Liebeck H, Matzat J, Ohly M, Rüddel HP, Rudolf S, Scheufele E, Simon R, Staats H, Ströhle A, Waldherr B, Wedekind D, Werner AM, Wiltink J, Wolters JP (2021) Deutsche s3-leitlinie behandlung von angststörungen, version 2. AWMF
- NICE (2013) Social anxiety disorder: recognition, assessment and treatment (full guideline). The British Psychological Society
- SIGN (2019) A guideline developer’s handbook (sign publication no. 50). Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh
- WHO (1991) Tenth revision of the international classification of diseases, chapter v (f): mental and behavioural disorders (including disorders of psychological development). Clinical descriptions and diagnostic guidelines. World Health Organization, Geneva
Cited by
Bandelow, B., Allgulander, C., Baldwin, D. S., Costa, D. L. D. C., Denys, D., Dilbaz, N., Domschke, K., Eriksson, E., Fineberg, N. A., Hättenschwiler, J., et al. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2086295 · Cited by 158
Self-citationBrandt, J., Bressi, J., Lê, M.-L., Neal, D., Cadogan, C., Witt-Doerring, J., Witt-Doerring, M., & Wright, S. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102507 · Cited by 77
Pharmacological Management of Borderline Personality Disorder and Common Comorbidities
Pascual, J. C., Arias, L., & Soler, J. (2023) · CNS Drugs · doi:10.1007/s40263-023-01015-6 · Cited by 71
Update on treatments for anxiety-related disorders
Lee, H. J., & Stein, M. B. (2023) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000841 · Cited by 43
Racz, J. I., Bialocerkowski, A., Calteaux, I. G., & Farrell, L. J. (2024) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-024-00478-3 · Cited by 45
Metadata
- Authors
- Bandelow, B., Werner, A. M., Kopp, I., Rudolf, S., Wiltink, J., & Beutel, M. E.
- Affiliations
- Universitätsmedizin Göttingen (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Association of the Scientific Medical Societies (DE)
- Helios Kliniken (DE)
- Corresponding author
- Bandelow, Borwin
- Venue
- European Archives of Psychiatry and Clinical Neuroscience
- Published
- 2021-10-05
- Volume
- 272
- Issue
- 4
- Pages
- 571-582
- ISSN
- 0003-9373 (ISSN-L)
- 0940-1334
- 1433-8491
- PMC
- PMC8490968
- OpenAlex
- W3204892548
- Cited by
- 90
- References
- 30
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 24 · 2023: 22 · 2022: 9
- FWCI
- 13.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- European Archives of Psychiatry and Clinical Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Funders
- Georg-August-Universität Göttingen
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- anxiety disorders, cognitive behavioral therapy, psychodynamic psychotherapy, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, pharmacotherapy, psychotherapy, virtual reality exposure therapy, online intervention, systemic therapy, treatment-resistant anxiety, patient preferences
- MeSH terms
- Internet-Based Intervention, Anxiety Disorders, Humans, Psychotherapy, Cognitive Behavioral Therapy, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The German Guidelines for the treatment of anxiety disorders: first revision. https://app.cochat.ai/papers/10.1007/s00406-021-01324-1
- The paper
- Bandelow, B., Werner, A. M., Kopp, I., Rudolf, S., Wiltink, J., & Beutel, M. E. (2022). The German Guidelines for the treatment of anxiety disorders: first revision. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-021-01324-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Fig. 1 PRISMA statement [24]. Newly included studies since 16/09/2013](https://figures.cochat.ai/paper-figures/112b1d01f28e4691a1cfdd41104d5b79/the-german-guidelines-for-the-treatment-of-anxiety-disorders-first-revision-figure-1.jpg)